How AstraZeneca’s antibody cocktail helps prevent COVID-19 in certain people


NEW HAVEN, Conn. (WTNH) — The FDA provided emergency authorization for a new COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination.

Specifically, the FDA authorized the AstraZeneca drug called Evusheld for adults and children 12 and older whose immune systems haven’t responded adequately to COVID-19 vaccines or have a history of severe allergic reactions to the shots.

Dr. Faiqa Cheema, director of transplant infectious disease at Hartford Hospital, explained how Evusheld works.

Watch the full interview in the player above.

Copyright 2022 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

Don't Miss

More Don't Miss